An early blocked sulfur amino acid auxotroph, Cephalosporium acremonium mutant 274-1 (which could be satisfied by methionine or cysteine), utilized organic sulfur compounds for cephalosporin C production in the following order of decreasing effectiveness; methionine > cystathionine > cysteine, despite the fact that cysteine is considered to be the immediate precursor of the antibiotic. When a genetic block was added to mutant 274-1 in the transsulfuration pathway from cysteine to methionine, the double mutant 11-8 (which grows on methonine but not cysteine) failed to produce cephalosporin C from cysteine even though enough methionine was added to support normal growth. Addition of the non-sulfur analogue, norleucine, resulted in antibiotic production from cysteine in the double mutant. These facts support the hypothesis that methionine stimulation of cephalosporin C production is due to a role of methionine other than that of sulfur donation.
The probable pathway of sulfur metabolism in Cephalosporium acremonium is shown in Fig. 1 . Although the immediate donor of sulfur to cephalosporin C is cysteine, this amino acid exerts little to no stimulatory effect on antibiotic production in a sulfate-containing medium. Methionine, on the other hand, is an excellent stimulator (for review, see reference 2). We suspect that the effect of methionine is a regulatory one. We have recently shown (6) that methionine has an obligatory role in stimulation of cephalosporin C production from sulfate even though the shortest path from sulfate to cephalosporin C (Fig. 1) does not include methionine. Using a methionine auxotroph (S-1), presumably blocked in transsulfuration between cystationine and homocysteine, we found that limitation of methionine in the presence of excess sulfate inhibited antibiotic production but not growth; i.e., the mutant produced no cephalosporin C from sulfate whereas its parent did produce the antibiotic. Although our calculations indicated that the small amount of methionine added for growth of mutant S-1 would not be expected to shut off sulfate assimilation, we felt that the known depressive effect of methionine on sulfate uptake (1) essary complication. The present work was undertaken to determine whether methionine was also obligatory for the conversion of cysteine to cephalosporin C using mutants blocked so that they cannot utilize sulfate as a source of sulfur.
MATERIALS AND METHODS Cultures. C. acremonium CW19 is a prototrophic strain obtained from Eli Lilly and Co. As described below, mutant 274-1 was obtained after ultraviolet irradiation of strain CW19 and is presumably blocked in conversion of sulfate to cysteine. It does not grow on sulfate as the sole sulfur source but does grow on cysteine, cystathionine, homocysteine, or methionine. Mutant 11-8 was isolated after ultraviolet irradiation of mutant 274-1. It responds only to homocysteine or methionine and is presumably a double mutant blocked both in conversion of sulfate to cysteine and in conversion of cysteine to methionine.
Media and cultural conditions. Growth media and culture growth conditions have been previously described (6) .
Cephalosporin C and dry cell weight determinations. Antibiotic titer and dry cell weight were determined as described in a previous paper (6) . ! Mutagenesis. C. acremonium CW19 after growth for 7 days on slants of the complete sporulation agar of Lemke and Nash (7) was used for mutagenesis. After adding 10 ml of 0. was similar for the two amino acids. It is thus clear that cysteine is much poorer than methionine as a sulfur source for antibiotic production. Cysteine was also examined at 0.3 g/liter, but growth and cephalosporin C production were poorer than at the higher concentrations shown in Fig. 2 .
Unlike cysteine, cystathionine supported rates and extents of growth as high as observed with methionine (Fig. 3) . Despite nearly identical growth, cephalosporin C production in cystathionine was slower and somewhat less extensive than that in methionine. A lower concentration of cystathionine (not shown) was less effective.
It was evident that as the sulfur-containing amino acids increased in metabolic distance from methonine and got closer to cephalosporin C (Fig. 1) , they became less able to stimulate antibiotic synthesis. These data supported the concept that methionine is more than a mere antibiotic precursor, i.e., sulfur.
Studies with double mutant 11-8. The data above suggested that sulfur intermediates must first be converted to methionine before they can stimulate antibiotic production. A test of this hypothesis became possible with the isolation of mutant 11-8, blocked in the path from cysteine to methionine and (like its parent) in the early pathway from sulfate to cysteine (Fig. 1) . We knew that the parent culture (274-1) could grow on cysteine and produce cephalosporin C. The question we now asked was whether growth in excess cysteine leads to antibiotic production when the path from cysteine to methionine is genetically blocked, i.e., in mutant 11-8.
Before using mutant 11-8 to answer the above question, one complication had to be eliminated. Our experimental plan was to supply methionine (the growth requirement of mutant 11-8) at a level low enough to support optimum growth but not antibiotic production. In addition, cysteine would be added to provide sulfur for antibiotic biosynthesis. However it is known (J. Niuesch, personal communication) that cysteine represses and inhibits methionine uptake in C. acremonium. Indeed, we found (Fig. 4) that addition of L-cysteine to the medium at the start of a fermentation inhibits growth of mutant 11-8. This problem was solved by intermittantly adding small amounts (0.3 g/liter) of cysteine at regular intervals starting 1.5 to 3 days after inoculation. Such a procedure resulted in no inhibition of growth.
The minimum methionine level which would just support optimum growth of mutant 11-8 was found to be 0.15 g of DL-methionine per liter ( Figure 6 shows that fairly good cephalosporin C production by parent 274-1 from cysteine occurred without exogenous methionine. However, mutant 11-8 could not produce cephalosporin C unless a high level of methionine was added. Since the parent produced respectable amounts of cephalosporin C in cysteine but the mutant could not, it is clear that blocking the path from cysteine to methionine virtually eliminated cephalosporin C production from cysteine. This demonstration of the essentiality of excess methionine for antibiotic synthesis from cysteine supports the hypothesis that methionine has a nonprecursor role.
Replacement of required methionine by norleucine. Our earlier studies with prototrophic strain CW19 (5) showed that methionine stimulation of cephalosporin C biosynthesis was duplicated by norleucine, a structural analogue of methionine which does not contain a sulfur atom. With mutant 11-8, we could now ask the following question. If we limit internal methionine but supply excess sulfur in the form of cysteine for antibiotic synthesis, can we now bring about cephalosporin C synthesis with norleucine? This question was answered by growing mutant 11-8 at a low concentration of DL-methionine with intermittant feeding of Lcysteine to a total concentration of 3.0 g/liter beginning 1.5 days after inoculation. Inadvertantly, a higher level of methionine (0.4 g/liter) than the minimum sufficient concentration (0.15 g/liter) was used in this experiment resulting in some production in the absence of norleucine supplementation. However the results are clear. The DL-norleucine dosage-response curve (Fig. 7) shows a direct relationship between cephalosporin C synthesis and the dose of norleucine. This finding further supports the hypothesis that methionine's control of antibiotic synthesis in the presence of excess cysteine is divorced from its role as a precursor of cephalosporin sulfur.
DISCUSSION
There is no doubt that methionine contributes sulfur to the cephalosporin C molecule (1, 9) . The controversial question is whether this donation of sulfur is responsible for stimulation of cephalosporin C biosynthesis. One would imagine that, if sulfur donation were important for stimulation, intermediates on the sulfur path between methionine and cephalosporin C could replace methionine as a stimulator of antibiotic formation. However prototrophic cultures of C. mildly stimulated or not stimulated at all by homocysteine, cystathionine, or cysteine (1, 3, 4, 9, 10) . In these earlier experiments, one has to be concerned with the possible complicating effect of sulfate assimilation; i.e., there was no guarantee that the organic sulfur source would be taken up and used in the presence of sulfate. The present experiments with mutant 274-1, blocked between sulfate and cysteine, eliminated this possible interference since good growth on an organic sulfur source insured that the compound had been taken up and used. Our studies with mutant 274-1 conclusively demonstrate that intermediates between methionine and cephalosporin C are unable to fully replace methionine for stimulation of antibiotic synthesis. The fact that the stimulatory activity of the sulfur amino acids decrease as they become metabolically more distant from methionine and closer to cephalosporin C indicates the relative unimportance of sulfur donation to the phenomenon of stimulation of cephalosporin C formation.
Our approach to studying the stimulatory role of methionine has been to limit intracellular methionine levels by mutation to methionine auxotrophy. Intracellular methionine concentrations are thus restricted by limiting the exogenous supply of methionine fed to methionine auxotrophs used in this study and in a previous one (6) . This technique has revealed that cephalosporin C biosynthesis is strictly dependent on the presence of methionine in excess of the amount required for normal growth. The significance of this observation is amplified by the fact that under these conditions sulfur is available for antibiotic synthesis in the form of either excess sulfate (mutant S-1 in reference 6) or excess cysteine (mutant 11-8 in the present study). Furthermore, in the presence of limited methionine and excess sulfur for antibiotic synthesis in the form of cysteine, the concentration of cephalosporin C produced is directly proportional to the concentration of added norleucine. Thus, the probable reason that cystathionine is more active than cysteine for mutant 274-1 is that it is metabolically closer to methionine than is cysteine and thus is more easily converted to the "inducer" of cephalosporin biosynthesis.
Niiesch et al. (9) obtained a mutant (8650 slp) with nutritional requirements similar to our mutant 274-1. They found that cysteine, cystathionine, and homocysteine supported even faster and more extensive growth than methionine but failed to replace methionine with respect to cephalosporin C production. A further observation (9) that they made was that this sulfate nonutilizing mutant produced considerably more antibiotic in the presence of methionine than did its prototrophic parent, i.e., 800 to 900 ,g/ml versus 100 ,g/ml. We were able to confirm this finding in that mutant 274-1 produced 800 to 1,100 ,gg of cephalosporin C per ml whereas prototrophic CW19 formed only about 400 ;g/ml. Niiesch and co-workers propose (J. Niiesch, personal communication) that higher cephalosporin C production by sulfate nonutilizing mutants is due to inability to form cysteine which is a repressor and inhibitor of methionine permease.
